Navigation Links
Quest Diagnostics Reports Second Quarter 2013 Financial Results
Date:7/18/2013

stics' common stockholders:Income from continuing operations

$

152.7$

175.2$

268.2$

331.3Income from discontinued operations, net of taxes

12.82.533.15.5Net income

$

165.5$

177.7$

301.3$

336.8Earnings per share attributable to Quest Diagnostics' common stockholders - basic:Income from continuing operations

$

0.99$

1.10$

1.72$

2.08Income from discontinued operations

0.080.020.210.04Net income

$

1.07$

1.12$

1.93$

2.12Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:Income from continuing operations

$

0.99$

1.09$

1.71$

2.06Income from discontinued operations

0.080.020.210.04Net income

$

1.07$

1.11$

1.92$

2.10Weighted average common shares outstanding:Basic

152.7158.5155.4158.4Diluted

154.1159.8156.7159.7Operating income as a percentage of net revenues15.9

%17.7

%14.3

%16.7

% Quest Diagnostics Incorporated and SubsidiariesConsolidated Balance SheetsJune 30, 2013 and December 31, 2012 (in millions, except per share data)June 30, 2013December 31, 2012(unaudited)AssetsCurrent assets:Cash and cash equivalents

$

148.3$

295.6Accounts receivable, net

946.8867.0Inventories

89.493.1Deferred income taxes

158.8174.2Prepaid expenses and other current assets

126.491.0Current assets held for sale

—40.2Total current assets

1,469.71,561.1Property, plant and equipment, net751.8755.8Goodwill5,665.85,535.8Intangible assets, net929.4872.2Other assets219.4204.6Non-current assets held for sale—354.4Total assets$

9,036.1$

9,283.9Liabilities and Stockholders' EquityCurrent liabilities:Accoun
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
2. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
3. A 50-year quest to isolate the thermoelectric effect is now over: Magnon drag unveiled
4. Survey Reveals Paternity Questions Loom for More Than One in 10 Americans
5. S.E.D. Labs to be Acquired by Quest Diagnostics
6. Quest Diagnostics STRATIFY JCV™ First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients
7. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
8. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
9. Mars, Incorporated Answers Question: How Does Feeding People and Pets Nurture Science and Discovery? At TEDMED 2012
10. Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrigs Disease)
11. Questcor Pharmaceuticals Expands Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 A study ... win races on the Formula 1 track could help ... collaboration between McLaren Applied Technologies (MAT), Stowhealth (a GP ... Suffolk is being funded by healthcare provider Simplyhealth. ... to collect data about the on-track performance of Vodafone ...
(Date:1/15/2014)... Rochester, NY (PRWEB) January 15, 2014 ... viruses can cause a major disease. One of these ... one of these diseases is rheumatoid arthritis (RA). Rheumatoid ... the body’s joints. As predicted by the theory, a ... EBV DNA in their bodies (1). , What ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 ... 1360 Almshouse Road, Warrington, Pa. , Details: ... solely dedicated to finding a cure for hepatitis B ... worldwide, will host its annual Crystal Ball on Friday, ... , Each year, the Crystal Ball attracts hundreds ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... SAN DIEGO, April 10 MedImmune today announced ... oncology,portfolio programs at the Annual Meeting of the ... commitment to,excellence in oncology research., "Cancer research ... at MedImmune and we,are proud to share data ...
... -- Sinovac Biotech Ltd. (Amex:,SVA), a leading provider ... General Meeting originally scheduled for March 25, 2008 ... During the April 8, 2008 Annual General ... Shangdi Xi Rd., Haidian District, Beijing,PRC, resolutions for ...
... CHICAGO, April 10 Advanced Life Sciences,Holdings, Inc. ... on a productive,meeting with the U.S. Food and ... New Drug Application (NDA) in the third quarter ... to treat mild-to-moderate,community acquired pneumonia (CAP)., (Logo: ...
Cached Biology Technology:MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 2MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 3Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 2Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 3
(Date:4/15/2014)... The global experts who study the deadliest infectious diseases ... G. Ksiazek, professors at the University of Texas Medical ... annual International Symposium on Filoviruses. The filoviruses include Ebola ... 90 percent of people infected. The current outbreak of ... than 100 deaths so far. , "This award ...
(Date:4/15/2014)... nanoparticle form could help reduce side effects by targeting ... scientists have developed nanoparticles that deliver one or two ... design particles that can carry any more than that ... devised a new way to build such nanoparticles, making ... drugs. In a paper published in the Journal ...
(Date:4/15/2014)... of Adelaide research into parasites of cuttlefish, squid ... astonishing life cycles, and shown how they may ... Researcher Dr Sarah Catalano has described 10 new ... the kidneys of cephalopods (cuttlefish, squid and octopus). ... to be described from Australian waters. , ...
Breaking Biology News(10 mins):International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Bizarre parasite may provide cuttlefish clues 2
... anti-cancer drugs block the enzymes that snip the kinks and ... cells but the drugs are increasingly encountering resistant bacteria ... Berkeley, biochemists could pave the way for new research into ... poisons for cancer cells and harmful bacteria. "The development ...
... foods is a top priority in tackling the obesity epidemic ... six months, the Institute of Medicine, United States Department of ... taken an interest in improving access to affordable and nutritious ... of epidemiology, and his team are tackling the same issue. ...
... Institute for Brain Science announced today that it has launched ... charting genes at work throughout the human brain. The ... extensive and detailed body of information about gene activity in ... or "turned on" where. In the coming years, the ...
Cached Biology News:Preventing cells from getting the kinks out of DNA 2Preventing cells from getting the kinks out of DNA 3Obesity remains an economic issue, Seattle obesity study finds 2Obesity remains an economic issue, Seattle obesity study finds 3Allen Institute for Brain Science launches Allen Human Brain Atlas 2Allen Institute for Brain Science launches Allen Human Brain Atlas 3
... The Zero Background Cloning Kit includes ... selection in E. coli. The pZErO-1 vector ... The small size of the Zeocin resistance ... increased ligation and transformation efficiencies. The kit ...
Polyethylene Glycol 8000, 1 kg. PEG 8000.Used in differential DNA precipitation. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Panomer 9 oligodeoxynucleotides are random primers that are labeled at the 5' end with our proprietary QSY 7 dye and they are useful for assessing microarray spot morphology, hybridization potential ...
Alkaline Phosphatase Stabilizer Solution, 1 L...
Biology Products: